1-2 of 2
Longen Zhou, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma

Nurulhuda Mustafa, PhD, Adina Huey Fang Nee, BSc, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, BSc, Yan Ting Hee, BSc, Viknesvaran Selvarajan, PhD, Longen Zhou, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2018-99-115566
Published: 2018
Journal Articles

Small Molecules Targeting Rad51 Recombinase Synergize with Imatinib and Overcome Imatinib-Resistance in CML.

Longen Zhou, PhD, Jiewen Zhu, Ph.D., Heiko Konig, M.D., Xiaoqin Lin, Ph.D., Ravi Bhatia, M.D., A. Richard Chamberlin, Ph.D., Phang-Lang Chen, Ph.D., Wen-Hwa Lee, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 466.
https://doi.org/10.1182/blood.V110.11.466.466
Published: 2007